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High Incidence and Endemic Spread of NDM-1-Positive
Enterobacteriaceae in Henan Province, China
Abstract
The emergence and spread of New Delhi metallo-β-lactamase 1 (NDM-1)-producing carbapenem-resistant
Enterobacteriaceae (CRE) present an urgent threat to human health. In China, the blaNDM-1 gene has been
reported mostly in Acinetobacter spp. but is rarely found in Enterobacteriaceae. Here, we report a high
incidence and endemic spread of NDM-1-producing CRE in Henan Province in China. Sixteen (33.3%) of
the 48 CRE isolates obtained from patients during June 2011 to July 2012 were positive for blaNDM-1, and the
gene was found to be carried on plasmids of various sizes (∼55 to ∼360 kb). These plasmids were readily
transferrable to recipient Escherichia coli by conjugation, conferred resistance to multiple antibiotics, and
belonged to multiple replicon types. The blaNDM-1-positive CRE isolates were genetically diverse, and six new
multilocus sequence typing (MLST) sequence types were linked to the carriage of NDM-1. Five of the
isolates were classified as extensively drug-resistant (XDR) isolates, four of which also carried the fosA3 gene
conferring resistance to fosfomycin, an alternative drug for treating infections by CRE. In each blaNDM-1-
positive CRE isolate, the blaNDM-1 gene was downstream of an intact ISAba125 element and upstream of the
bleMBL gene. Furthermore, gene environment analysis suggested the possible transmission of blaNDM-1-
containing sequences from Acinetobacter spp. to Klebsiella pneumoniae and Klebsiella oxytoca. These
findings reveal the emergence and active transmission of NDM-1-positive CRE in China and underscore the
need for heightened measures to control their further spread.
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The emergence and spread of NewDelhi metallo--lactamase 1 (NDM-1)-producing carbapenem-resistant Enterobacteriaceae
(CRE) present an urgent threat to human health. In China, the blaNDM-1 gene has been reported mostly in Acinetobacter spp. but
is rarely found in Enterobacteriaceae. Here, we report a high incidence and endemic spread of NDM-1-producing CRE in Henan
Province in China. Sixteen (33.3%) of the 48 CRE isolates obtained from patients during June 2011 to July 2012 were positive for
blaNDM-1, and the gene was found to be carried on plasmids of various sizes (55 to360 kb). These plasmids were readily trans-
ferrable to recipient Escherichia coli by conjugation, conferred resistance to multiple antibiotics, and belonged to multiple repli-
con types. The blaNDM-1-positive CRE isolates were genetically diverse, and six newmultilocus sequence typing (MLST) sequence
types were linked to the carriage of NDM-1. Five of the isolates were classified as extensively drug-resistant (XDR) isolates, four
of which also carried the fosA3 gene conferring resistance to fosfomycin, an alternative drug for treating infections by CRE. In
each blaNDM-1-positive CRE isolate, the blaNDM-1 gene was downstream of an intact ISAba125 element and upstream of the
bleMBL gene. Furthermore, gene environment analysis suggested the possible transmission of blaNDM-1-containing sequences
from Acinetobacter spp. to Klebsiella pneumoniae and Klebsiella oxytoca. These findings reveal the emergence and active trans-
mission of NDM-1-positive CRE in China and underscore the need for heightenedmeasures to control their further spread.
Carbapenems are the last-resort antibiotics against drug-resis-tant Gram-negative bacterial pathogens (1). However, car-
bapenem-resistant Enterobacteriaceae (CRE) are increasingly re-
ported in health care-associated infections (HAIs) and are
considered an urgent threat to human health by the Centers for
Disease Control in the United States (2). Multiple genes confer-
ring carbapenem resistance have been reported, which encode
various types of carbapenemases (1). New Delhi metallo--lacta-
mase 1 (NDM-1), an Ambler class B metallo--lactamase (MBL),
hydrolyzes all -lactams (including carbapenems) but monobac-
tams and was first identified in Klebsiella pneumoniae and Esche-
richia coli isolated from a Swedish patient who was hospitalized in
India in 2008 (3). Subsequently, the wide distribution of NDM-1-
producing Enterobacteriaceae in India, Pakistan, and the United
Kingdomwas reported (4), and the Indian subcontinent was con-
sidered the main reservoir of NDM-1 producers (5). To date, the
NDM-1-producing pathogens have been reported in more than
40 countries and have become a significant threat for public health
worldwide (6).
In China, the blaNDM-1 gene was first identified in four non-
clonal Acinetobacter baumannii isolates (7). Subsequent studies
found that Acinetobacter spp. were the main species carrying this
gene, but the carriage of blaNDM-1 was at a low frequency (1.5%)
(7–9). Carbapenem resistance in Enterobacteriaceae in China has
been mainly associated with Klebsiella pneumoniae carbapen-
emases (KPCs), such as KPC-2, and MBLs (such as IMP-4) other
than NDM-1 (10, 11). NDM-1-mediated carbapenem resistance
in Enterobacteriaceae in China has been rarely reported; so far
there have been only two confirmed cases of NDM-1-producing
K. pneumoniae and E. coli infections in China (12, 13). A recent
study detected a high infection rate (14.8%)ofNDM-1-producing
bacteria in clinical fecal samples frommultiple hospitals in China,
but none of the NDM-1-carrying bacteria belonged to Enterobac-
teriaceae (14). These observations suggested that NDM-1 was not
prevalent in CRE isolates from China. However, in this study, we
demonstrated the high incidence and endemic spread of NDM-1-
producing Enterobacteriaceae in Henan Province in China. Addi-
tionally, we conducted molecular characterization of the blaNDM-1-
positive CRE isolates, revealing new molecular epidemiological
features of CRE in China.
MATERIALS AND METHODS
Bacterial isolates, identification, and antimicrobial susceptibility test-
ing.A total of 48CRE (imipenem [MIC,4g/ml] ormeropenem [MIC,
2 g/ml]) isolates, including 6 E. coli, 33 K. pneumoniae, 1 Klebsiella
oxytoca, 5 Enterobacter cloacae, and 3 Citrobacter freundii isolates, were
collected from diagnostic laboratories in three hospitals located in the
middle (Zhengzhou, n 40), western (Sanmenxia, n 4), and southern
(Zhumadian, n  4) regions of Henan Province (north-central China).
These isolates were obtained from June 2011 to July 2012. All isolates were
identified using the Vitek 2 system (bioMérieux, France) and 16S rRNA
gene sequencing. Antimicrobial susceptibilities for the blaNDM-1-positive
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isolates and transconjugants were initially tested using the Vitek 2 system
(bioMérieux, France) and then were followed by measuring the MIC us-
ing the brothmicrodilutionmethod (for ampicillin-sulbactam, piperacil-
lin-tazobactam, cefazolin, cefotetan, ceftazidime, cefepime, imipenem,
ertapenem, ciprofloxacin, levofloxacin, gentamicin, amikacin, and az-
treonam), the Etest (AB bioMérieux, Sweden) (for chloramphenicol, tet-
racycline, tigecycline, and colistin), and the agar dilution method (for
fosfomycin), respectively. The standard microbroth and agar dilution
methods were performed according to the guideline M07-A9 of the Clin-
ical and Laboratory Standards Institute (CLSI) (15). Etests were con-
ducted according to packet insert instructions usingMueller-Hinton agar
(MHA). Fresh bacterial colonies taken directly from MHA plates that
were incubated at 37°C for 16 to 20 h were resuspended in sterileMueller-
Hinton broth to obtain a suspensionwithMcFarland standard 0.5 turbid-
ity.E. coliATCC25922was usedas thequality control. TheMICresultswere
interpreted according to the CLSI guidelineM100-S22 (15). The 2013 Euro-
pean Committee on Antimicrobial Susceptibility Testing breakpoints were
used (available at http://www.eucast.org/clinical_breakpoints/) for colistin
and tigecycline.
Detection of resistance determinants. The modified Hodge test and
the imipenem-EDTA double-disk synergy test were performed according
to the CLSI guidelines to detect carbapenemase activity (15). PCR and
nucleotide sequencing were employed to screen for the presence of car-
bapenemase-encoding genes, including blaOXA-48-like, blaIMP, blaVIM,
blaKPC, and blaNDM. In addition, extended-spectrum -lactamase (ESBL)
genes, plasmid-mediated AmpC genes, 16S rRNA methyltransferase
genes, and fosfomycin resistance determinants were also detected by use
of the methods described previously (16–20).
Bacterial genotyping. Pulsed-field gel electrophoresis (PFGE) of
XbaI-digested genomic DNA of blaNDM-1-positive CRE and reference
marker Salmonella H9812 was performed using a contour-clamped ho-
mogeneous electric field (CHEF)-Mapper XA PFGE system (Bio-Rad,
USA)with a 5- to 35-s linear ramp for 22 h at 6 V/cm at 14°C. The running
buffer was 0.5 Tris-boric acid-EDTA (TBE) without thiourea. The gel
imagewas captured using aBio-RadUniversalHood II gel imaging system
(Bio-Rad, USA). The dendrograms were constructed from the PFGE data
by the unweighted-pair group method with arithmetic mean (UPGMA)
with the Dice coefficient using InfoQuest FP software version 4.5 (Bio-
Rad Laboratories, USA). Multilocus sequence typing (MLST) for clinical
K. pneumoniae and E. coli isolates was performed following the methods
described previously (21, 22). The allelic profiles and sequence types
(STs) were assigned using online databases (see http://www.pasteur.fr
/recherche/genopole/PF8/mlst/Kpneumoniae.html for K. pneumoniae
and http://mlst.warwick.ac.uk/mlst/dbs/Ecoli for E. coli).
Conjugation andplasmid analysis.Conjugative assayswereperformed
according to the method described previously (23). The blaNDM-1-positive
CRE served as the donors, while E. coli J53 (sodium azide resistant) was
used as the recipient strain. Transconjugants were selected on Mueller-
Hinton (MH) agar supplemented with sodium azide (100 g/ml) and
imipenem (1 g/ml). The presence of the blaNDM-1 gene and other resis-
tance genes in transconjugants were identified using PCR and DNA se-
quencing, and antimicrobial susceptibility was also determined.
S1-PFGE and Southern blotting were conducted to estimate sizes of
blaNDM-1 plasmids (24). Briefly, whole-cell DNA of clinical and transcon-
jugant strains in agarose gel plugs was treated with S1 nuclease (TaKaRa,
Dalian, China), then separated by PFGE under the following conditions:
0.5 Tris-borate-EDTA, 1% agarose solution for 18 h at 6 V/cm and
14°C, with a pulse angle of 120° and the pulse time linearly ramped from
2.16 s to 63.8 s. Linear plasmids generated by S1-PFGEwere transferred to
nylonmembranes (Millipore, USA), hybridized with digoxigenin-labeled
TABLE 1 Characteristics of blaNDM-1-positive CRE isolates
Isolatea
Clinical features Additional resistance determinantsb
MLSTc
Plasmid type
carrying blaNDM-1/
plasmid size (kb)
Patient
age/sex Specimen Diagnosis/wardd Outcome -Lactamases
16S rRNA
methylase Others
EC-01 76 yr/female Urine Pyelonephritis complicated with
diabetes/endocrinology
Discharge    ST1237 Untypeable/230
EC-03 58 yr/male Blood Severe acute pancreatitis/ICU Death TEM-1, CTX-M-55, CMY-30 RmtB FosA3 ST361 A/C/180
EC-13 6 days/male Blood Neonatal sepsis/NICU Discharge TEM-1, CMY-30   ST40 FIB/310
EC-24 56 yr/female Urine Diabetes and urinary tract
infections/endocrinology
Discharge CTX-M-15  FosA3 ST205 A/C/230
EC-SMX3 42 yr/male Blood Multiple injuries/EICU Discharge TEM-1, CTX-M-15, CMY-30   ST410 I1/60
EC-SMX5 63 yr/female Sputum Lung cancer/oncology Discharge CTX-M-15, CMY-30   ST361 A/C/260
KP-07 72 yr/female Blood Intracranial hemorrhage
associated with cerebral
infections/neurosurgery
Discharge    ST11 Untypeable/55
KP-09 1 yr/male Urine Multiple contusions as a result
of a car accident/PICU
Discharge TEM-1 RmtB  ST889 A/C/245
KP-40A 10 days/male Blood Neonatal sepsis/NICU Death TEM-1, CTX-M-15   ST966 A/C/e
KP-41 9 mo/female Blood Septicemia/PICU Death    ST113 N/55
KO-ZMD8 75 yr/male Urine Nephrotic
syndrome/nephrology
Discharge    ND Untypeable/55
ECL- ZMD10 49 yr/male Wound Extensive burns/burn unit Discharge  ArmA FosA3 ND Untypeable/360
ECL- ZMD12 21 yr/female Blood Severe aplastic
anemia/hematology
Death  ArmA  ND A/C/55
ECL-36 15 days/male Sputum Lung infections and
asphyxia/NICU
Death MIR-2   ND A/C/160
CF-SMX4 67 yr/male Urine Nephropathy/nephrology Discharge CMY-73   ND Untypeable/55
CF-25 62 yr/male Urine Cerebral hemorrhage and lung
infection/neurosurgery
Discharge CMY-73 ArmA FosA3 ND A/C/170
a EC, E. coli strains; KP, K. pneumoniae strains; KO, K. oxytoca strains; ECL, E. cloacae strains; CF, C. freundii strains.
b Resistance markers that are cotransferred with blaNDM-1 by conjugation are underlined. Minus signs indicate negative results. PCR screening included blaTEM; blaSHV;
blaOXA-1-like; blaCTX-M groups 1, 2, 8, 9, and 26; blaOXA-48-like; blaIMP; blaVIM; blaKPC; blaNDM; 6 groups of blaAmpC -lactamase genes; and fosfomycin resistance genes fosA, fosB,
fosC, and fosX as well as the armA, rmtA-rmtE, and npmA 16S methylase genes.
c STs that are newly identified harboring blaNDM-1 in this study are underlined. MLST, multilocus sequence typing; ND, not determined.
d ICU, intensive care unit; NICU, newborn ICU; EICU, emergency ICU; PICU, pediatric ICU.
e S1-PFGE and Southern blotting failed to detect the blaNDM-1 plasmid in KP-40A and its transconjugant, although the blaNDM-1 gene was detected in them by PCR and sequencing.
Qin et al.
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blaNDM-1-specific probes, and detected using a nitroblue tetrazolium-5-
bromo-4-chloro-3-indolylphosphate (NBT-BCIP) color detection kit
(Roche Applied Sciences, Germany) according to the recommendations
of the supplier. Plasmid replicons were determined using the PCR-based
replicon typing method (25).
The genetic environment surrounding blaNDM-1 was investigated by
PCR mapping and sequencing, and the Acinetobacter lwoffii plasmid of
pNDM-BJ01 (accession no. JQ001791) and E. coli plasmid of pBJ01 (Gen-
Bank accession no. JX296013) were used as the references. PCR primers
were designed from the reference sequences and are listed in Table S1 in
the supplemental material. The locations of the primers are also shown
(see Fig. 3).
Nucleotide sequence accession number. The sequence described in
this paper has been submitted to GenBank under the accession no.
KF985036 (K. oxytoca isolate ZMD8).
RESULTS AND DISCUSSION
Identification of blaNDM-1-positive isolates from hospital pa-
tients. Among the 48 CRE, 16 (16/48 [33.3%]) were identified as
blaNDM-1 positive, including 6 E. coli, 4 K. pneumoniae, 1 K. oxy-
toca, 3 E. cloacae, and 2 C. freundii isolates, which were obtained
from specimens of blood (n 7), urine (n 6), and sputum (n
2) and a burn site (n  1) (Table 1). Additionally, 26 K. pneu-
moniae isolates harbored blaKPC-2, 2 isolates (1K. pneumoniae and
1 E. cloacae) carried blaIMP-4, and the remaining isolates did not
contain the carbapenemase genes (blaNDM, blaKPC, blaVIM, blaIMP,
and blaOXA-48-like) screened in this study. The 16 blaNDM-1-positive
CRE were from three hospitals in three different cities in Henan
Province. The clinical data associated with the 16 isolates were
summarized in Table 1. These patients were diagnosed with dif-
ferent clinical diseases, but none of the patients had a history of
foreign travel. Notably, 5 patients, including 3 young children,
died of infections. All of the patients who died, except an infant,
had a positive blood culture for CRE and two of the patients had
septicemia (Table 1). Thus, the death rate among the patients
infectedwith a blaNDM-1-positive isolate was 31%,which is higher
than previously reported rates in confirmed cases associated
with NDM-1-producing bacteria worldwide (26). These results
TABLE 2 Antibiotic susceptibilities of blaNDM-1-positive CRE and their transconjugants
Isolatea
Antibioticb susceptibility (g/ml) to:
SAM TZP CFZ CTT CAZ FEP IPM ETP CIP LVX GEN AMK SXT ATM CHL TET FOF TGC CST
EC-01 	256 	256 	256 	256 	256 	256 8 16 2 2 64 16 40 8 256 256 8 0.75 0.5
EC-03 	256 	256 	256 	256 	256 256 	32 32 	32 	32 	256 	256 	320 256 256 256 512 0.5 0.5
EC-13 	256 	256 	256 	256 	256 	256 4 16 8 2 32 16 	320 64 256 256 8 0.38 1
EC-24 	256 	256 	256 	256 	256 	256 	32 32 	32 	32 32 8 	320 128 256 256 512 3 1
EC-SMX3 	256 	256 	256 	256 	256 	256 4 8 	32 	32 64 128 	320 256 4 2 32 0.5 2
EC-SMX5 	256 	256 	256 	256 	256 	256 32 16 	32 	32 32 2 	320 128 256 256 8 0.5 2
KP-07 	256 	256 	256 	256 	256 	256 8 	32 	32 	32 1 2 	320 256 128 2 8 3 1
KP-09 	256 	256 	256 	256 	256 	256 	32 4 1 1 	256 	256 	320 32 256 256 32 3 1
KP-40A 	256 	256 	256 	256 	256 	256 	32 16 0.25 0.25 64 2 	320 	256 256 256 32 6 1
KP-41 	256 	256 	256 	256 	256 	256 	32 	32 0.25 0.25 1 2 	320 1 6 2 8 3 0.5
KO-ZMD8 	256 	256 	256 	256 	256 	256 8 16 0.25 0.5 32 2 	320 128 256 256 32 0.5 0.5
ECL-ZMD10 ND 64 ND ND 	256 	256 8 32 	32 	32 	256 	256 	320 256 256 256 128 1 1
ECL-ZMD12 ND 	256 ND ND 	256 	256 8 32 	32 	32 	256 	256 	320 	256 256 256 32 3 2
ECL-36 ND 	256 ND ND 	256 	256 32 	32 0.25 0.25 32 2 	320 256 8 4 8 2 1
CF-SMX4 ND 	256 ND ND 	256 	256 	32 	32 8 4 16 2 20 256 6 128 8 1 1
CF-25 ND 	256 ND ND 	256 	256 	32 	32 	32 	32 	256 	256 	320 64 48 256 512 0.75 0.5
E. coli transconjugant
strains
EC-01-J53 	256 64 	256 	256 	256 32 8 16 0.25 0.25 32 2 20 4 256 256 8 1 0.5
EC-03-J53 	256 32 	256 	256 	256 8 	32 8 0.25 0.25 	256 	256 	320 128 256 2 512 0.19 1
EC-13-J53 	256 64 	256 32 	256 4 4 4 0.25 0.25 16 2 	320 32 128 128 8 0.25 1
EC-24-J53 	256 	256 	256 	256 	256 	256 32 16 0.25 0.25 8 2 20 2 256 256 8 0.19 1
EC-SMX3-J53 	256 	256 	256 	256 	256 	256 4 8 8 16 32 32 	320 64 4 0.75 8 0.19 1
EC-SMX5-J53 	256 64 	256 	256 	256 16 32 16 0.25 0.25 32 2 20 1 256 8 16 1 0.5
KP-07-J53 	256 	256 	256 	256 	256 	256 8 16 8 16 1 2 	320 128 24 2 8 0.5 1
KP-09-J53 	256 64 	256 4 	256 2 4 4 0.25 0.25 1 2 20 1 8 256 32 2 1
KP-40A-J53 	256 	256 	256 32 	256 8 8 4 0.25 0.25 32 2 	320 128 256 256 8 1 1
KP-41-J53 	256 	256 	256 	256 	256 8 8 16 0.25 0.25 1 2 40 1 4 2 8 0.75 1
KO-ZMD8-J53 	256 	256 	256 	256 	256 	256 8 16 0.25 0.25 8 2 	320 128 256 256 16 0.75 1
ECL-ZMD10-J53 	256 64 	256 	256 	256 	256 4 16 32 16 	256 	256 	320 128 256 256 128 1.5 0.5
ECL-ZMD12-J53 	256 	256 	256 	256 	256 	256 8 32 32 32 	256 16 20 	256 256 256 32 3 1
ECL-36-J53 	256 64 	256 	256 	256 	256 32 	32 0.25 0.25 32 2 	320 1 8 8 8 1.5 1
CF-SMX4-J53 	256 64 	256 32 	256 	256 8 16 0.25 0.25 2 2 20 2 4 128 8 1 1
CF-25-J53 	256 64 	256 16 	256 2 8 4 0.25 0.25 32 2 20 4 48 128 128 0.25 1
EC J53 2 4 4 4 1 1 1 0.5 0.25 0.25 1 2 20 1 8 2 2 0.25 0.5
a All of the blaNDM-1-positive isolates were multidrug-resistant (MDR) strains, and the XDR isolates are highlighted in bold type. EC, E. coli strains; KP, K. pneumoniae strains; KO,
K. oxytoca strains; ECL, E. cloacae strains; CF, C. freundii strains. For the transconjugants, all were E. coli J53 harboring plasmids from the respective clinical isolates.
b SAM, ampicillin-sulbactam (1/0.5–256/128) (the numbers in parentheses indicate the test range [g/ml] for each agent); TZP, piperacillin-tazobactam (0.5/4–256/4); CFZ,
cefazolin (0.5–256); CTT, cefotetan (0.03–256); CAZ, ceftazidime (0.03–256); FEP, cefepime (0.015–256); IPM, imipenem (0.06–32); ETP, ertapenem (0.004–32); CIP,
ciprofloxacin (0.004–32); LVX, levofloxacin (0.008–32); GEN, gentamicin (0.25–256); AMK, amikacin (0.5–256); ATM, aztreonam (0.06–256); CHL, chloramphenicol (0.016–
256); TET, tetracycline (0.016–256); FOF, fosfomycin (0.25–512); TGC, tigecycline (0.016–256); CST, colistin (0.016–256). The MICs of trimethoprim-sulfamethoxazole (SXT)
were obtained by the Vitek 2 system. ND, not determined (E. cloacae and C. freundii are intrinsically resistant to SAM, CFZ, and CTT).
NDM-1-Producing Enterobacteriaceae
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revealed the high prevalence of blaNDM-1-positive CRE in the
hospitals of Henan Province and their association with a high
mortality rate.
Antimicrobial susceptibility patterns and resistance deter-
minants.All of theNDM-1-positive CRE isolates were resistant to
carbapenems and cephalosporins but susceptible to colistin
(MICs of 2 mg/liter) (Table 2). Molecular characterization
showed thatmost of the E. coli (5/6) and half of theK. pneumoniae
isolates (2/4) harbored ESBL genes, AmpC genes, or both (Table
1). Other carbapenemase-encoding genes, including blaKPC,
blaVIM, blaIMP, and blaOXA-48-like, were not detected in any of the
NDM-1-positive CRE isolates. Six isolates (EC-24, KP-07, KP-09,
KP-40A, KP-41, andZMD12) demonstrated tigecycline resistance
according to the EUCAST clinical breakpoint, with MICs of 2
g/ml (Table 2).More significantly, five isolates, including EC-03,
CF-25, ECL-ZMD10 (susceptible only to tigecycline and colistin),
EC-24 (susceptible only to amikacin and colistin), and ECL-
ZMD12 (susceptible only to fosfomycin and colistin), were iden-
tified as extensively drug-resistant (XDR) bacteria (nonsuscep-
tible to1 agent in all of the 17 but2 antimicrobial categories,
including glycylcyclines and polymyxins used for treatment of in-
fections caused by Enterobacteriaceae) according to the definitions
described byMagiorakos et al. (27). In addition, four isolates (EC-
03, EC-24, ECL-ZMD10, and CF-25) harbored a plasmid-medi-
ated fosfomycin resistance gene, fosA3. This gene was found only
in CTX-M-producing E. coli isolated from Asian countries (28),
and our finding represents the first report of NDM-1-producing
CRE harboring the fosA3 gene encoding fosfomycin resistance.
Generally, the resistance rate of fosfomycin in E. coli was low (1%
to 3%) worldwide, and fosfomycin is also used as an alternative
choice for treating infections caused by ESBL-producing and even
carbapenemase-producing Enterobacteriaceae (29). However, the
occurrence of fosfomycin resistance in NDM-1-producing CRE
observed in this study will further limit clinical therapeutic op-
tions.
Genotyping. PFGEwas successfully performed with 4 E. coli, 3
K. pneumoniae, 1K. oxytoca, 3 E. cloacae, and 2C. freundii isolates,
and their patterns were completely different (Fig. 1). Three iso-
lates, including EC-24, EC-SMX5, and KP-40A, were nontypeable
by PFGE, as their XbaI-digested genomic DNA failed to yield dis-
tinct bands despite multiple efforts to repeat the experiment.
MLSTwas performed for all of the blaNDM-1-positive E. coli andK.
pneumoniae isolates, since the two species of Enterobacteriaceae
were the major ones carrying the blaNDM-1 gene. Five MLST types
were identified among the six E. coli isolates. Similarly, fourMLST
types were identified among the four K. pneumoniae isolates
(Table 1). Two E. coli isolates (EC-03 and EC-SMX5) obtained
from two different hospitals located in geographically separated
areas (Zhengzhou and Sanmenxia) shared the same ST type
(ST361), suggesting they were clonally related. Overall, our data
showed that clonally diverse NDM-1-producing Enterobacteria-
ceae contributed to the dissemination of blaNDM-1in Henan Prov-
ince.
This study linked for the first time six new STs (ST40, ST205,
and ST1237 [E. coli] and ST113, ST889, and ST966 [K. pneu-
moniae]) to the production of NDM-1. E. coli ST410 andK. pneu-
moniae ST11were frequently detected in clinical isolates of NDM-
1-producing E. coli and K. pneumoniae from different countries,
suggesting that they play an important role in the dissemination of
blaNDM-1 (30). In addition, the NDM-1-producing E. coli ST361
isolate was also found in New Zealand (31).
Plasmid analysis. S1-PFGE and Southern blot analysis showed
that the presence of the blaNDM-1 gene in the 16 CRE isolates was
located on diverse plasmids, with sizes ranging from55 to360
FIG 1 PFGE-based dendrograms showing the genetic relationships of 13 blaNDM-1-positive CRE isolates. EC-24, EC-SMX5, and KP-40A failed to yield bands by
XbaI-PFGE and were not included.
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kb. Furthermore, half of the blaNDM-1 plasmids belonged to plas-
mid replicon type IncA/C (Table 1 and Fig. 2). This broad-host-
range plasmid wasmost frequently reported for carrying blaNDM-1
and other resistance genes, and it is widely disseminated among
Gram-negative bacteria worldwide (6, 32).
Conjugative assays revealed that all of the blaNDM-1 plasmids
were successfully transferred to E. coli J53 from the 16 donors by
conjugation. The 16 transconjugants all showed resistance to car-
bapenems and cephalosporins (Table 2). Moreover, the blaNDM-1
plasmids in all the transconjugants remained stable after 10 pas-
sages in the absence of imipenem selection. In addition, resistance
genes such as blaTEM-1, blaCTX-M-15/55, blaCMY-30, rmtB, armA, and
fosA3 were cotransferred to E. coli J53 with the blaNDM-1 gene in
several isolates (Table 2). Interestingly, we found that the blaNDM-1
and fosA3 geneswere carried by distinct IncA/Cplasmids in EC-03
(180 kb for blaNDM-1 and90 kb for fosA3) andCF-25(170 kb
for blaNDM-1 and310 kb for fosA3) (Fig. 2), but the two plasmids
in each isolate were cotransferred to the E. coli J53 recipient, sug-
gesting that both were mobile or one of them acted as a helper
plasmid for the other to transfer. In contrast to the above two
isolates, ECL-ZMD10 harbored a large plasmid (360 kb) of an
untypeable replicon type, which carried both blaNDM-1 and fosA3
and was transferred to E. coli J53 by conjugation (Fig. 2 and Table
2). Several recent studies demonstrated that the fosA3 gene was
associated with blaCTX-M genes and carried by plasmids belonging
to different replicon types, including F, N, B/O, and I1 in E. coli
andK. pneumonia (33–35). In our study, this genewas found to be
carried by a conjugative blaNDM-1 plasmid in a species (E. cloacae)
other than E. coli and K. pneumonia, implying the further spread
of fosA3 among Enterobacteriaceae. Moreover, the E. coli J53 re-
cipient became an XDR strain after accepting the ECL-ZMD10
plasmid by conjugation, indicating multiple resistance determi-
nants might be carried by this blaNDM-1 plasmid. Additional stud-
ies are ongoing to characterize this plasmid. In vivo interspecies
dissemination of IncA/C plasmids carrying blaNDM-1was de-
scribed in previous studies (23, 36). However, all of the NDM-1
plasmids identified in the 16 blaNDM-1-positive CRE isolates were
different either in size or replicon type, suggesting that insertion
elements or transposons may play important roles in the mobili-
zation of blaNDM-1.
Genetic environments of blaNDM-1.The genetic environments
surrounding the blaNDM-1 gene were detected by PCR mapping
and DNA sequencing. The bleomycin resistance gene bleMBL, fol-
lowed by a truncated trpF gene, was located immediately down-
stream of the blaNDM-1 gene in all of the 16 CRE isolates (Fig. 3).
The three-gene cluster (blaNDM-1-bleMBL-
trpF) was highly con-
served and was also previously reported in E. coli plasmids
(pNDM-HK, pBJ01, and pNDM_Dok01) and A. lwoffii plasmids
(pNDM-BJ01 and pNDM-BJ02) (37) (Fig. 3). It was reported that
blaNDM-1 and bleMBL are under the control of the samepromoter in
front of blaNDM-1, and this structure may facilitate the spread of
NDM-1when under the selective pressure of bleomycin-likemol-
FIG2 Detection of blaNDM-1- (I) and fosA3- (II) carrying plasmids by PFGE and Southern hybridization. (I) S1-PFGE (top) and Southern blotting (bottom)with
blaNDM-1 specific probe. Lanes M, marker (Salmonella H9812); lane 1, EC-01-J53; lane 2, EC-SMX5-J53; lane 3, EC-SMX3; lane 4, KP-41; lane 5, KP-40A
(untypeable); lane 6, KP-09; lane 7, KP-07; lane 8, KO-ZMD8; lane 9, ECL-ZMD10; lane 10, ECL-ZMD12; lane 11, ECL-36; lane 12, CF-SMX4; lane 13,CF-25;
lane 14, EC-03-J53; lane 15, EC-24-J53; lane 16, EC-13. The arrows indicate the locations of the plasmids hybridized to theNDM-1 probe. (II) S1-PFGE (left) and
Southern blotting (right) with fosA3-specific probe. Lane M, marker (Salmonella H9812); lanes 1, ECL-ZMD10-J53; lanes 2, CF-25-J53; lanes 3, EC-03-J53.
NDM-1-Producing Enterobacteriaceae
August 2014 Volume 58 Number 8 aac.asm.org 4279
 o
n
 Septem
ber 27, 2017 by IO
W
A STATE UNIVERSITY
http://aac.asm
.org/
D
ow
nloaded from
 
ecules in the environment (38). The entire ISAba125 element was
detected immediately upstreamof the blaNDM-1 gene in each of the
16 isolates. It has been documented that ISAba125 provides the
35 region of the promoter sequence for blaNDM-1 in all reported
cases (37). For two K. pneumonia isolates (KP-09 and KP-41) and
oneK. oxytoca isolate (KO-ZMD8), a 5,859-bp DNA segment was
sequenced and it contained eight genes, including ISAba125,
blaNDM-1, bleMBL, 
trpF, dsbC, cutA1, groES, and groEL (Fig. 3).
This DNA segment is highly homologous (	99%) to previously
identified sequences inAcinetobacter spp. fromChina (9, 39) (Fig.
3), suggesting the possible transmission of blaNDM-1-containing
sequences between Acinetobacter spp. and Enterobacteriaceae.
Considering that blaNDM-1 was mostly reported in Acinetobacter
spp. in China, our finding suggests that Acinetobacter may have
served as a reservoir for the dissemination of NDM-1 toward En-
terobacteriaceae.
The sporadic emergence of NDM-1-producing E. coli and K.
pneumoniae in mainland China has been reported in two recent
studies (12, 13). Additionally, several cases of NDM-1-producing
CRE reported from Hong Kong and Taiwan were also epidemio-
logically linked to mainland China (40–42). Here, we report our
study of a cluster of blaNDM-1-positive CRE from patients in
Henan Province. Together, these findings strongly suggest that
NDM-1-producing CRE is spreading in mainland China. Com-
pared to previously reported studies, our work revealed several
important findings on CRE in China. First, a high incidence
(33.3%) of NDM-1-producing Enterobacteriaceae was observed
among the examined CRE, which is much higher than previously
realized and suggests that blaNDM-1-positive CRE is endemic in
Henan Province. Second, none of the patients carrying NDM-1-
producing CRE had a history of foreign travel, suggesting that the
NDM-1-carrying CRE were endogenous to the region and likely
originated locally due to antibiotic selection and spread of the
resistance gene. Third, most of the NDM-1-producing E. coli and
K. pneumoniae isolates identified in this study belong to new
MLST sequence types that have not been reported previously, sug-
gesting the active spread of blaNDM-1 among Enterobacteriaceae in
China. These findings provide new insights into the epidemiology
of CRE in China.
In summary, our study demonstrated a high incidence of
NDM-1-producing CRE from patients with different clinical dis-
eases in Henan Province. These NDM-1-positive isolates were ge-
netically diverse and carried plasmids of various sizes that were
readily transferred by conjugation. Our results suggest that
mainland China is becoming an endemic reservoir for NDM-1-
producing Enterobacteriaceae. In addition, the emergence of XDR
Enterobacteriaceae carrying conjugative blaNDM-1 plasmids cohar-
boring other resistance determinants such as fosA3 is alarming,
FIG 3 Comparison of the blaNDM-1 gene environments identified in this study with others published previously. (A) blaNDM-1-surrounding sequences in A.
baumannii 161/07 (GenBank accession no.HQ857107),A. lwoffii pNDM-Bj01 (JQ001791), and non -baumannii Acinetobacter spp. plasmids (JQ080305). (B and
D) the blaNDM-1 gene environments identified in this study; the names of the isolates are listed on the right of each panel.(C, E and F) blaNDM-1-surrounding
sequences in E. coli BJ01 (JX296013), E. coli pNDM-HK (HQ451074), and E. coli pNDM-1_Dok01 (AP012208), respectively. The boxed arrows indicate the
positions and directions of transcription of the genes. The gray-shaded areas represent regions sharing	99% DNA identity. Positions of the primers used for
PCR mapping are indicated by arrows.
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as spread of these isolates will seriously limit options for clini-
cal treatment in future. Thus, enhanced efforts are urgently
needed to control the further spread of NDM-1-producing En-
terobacteriaceae.
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